Brief: dsm-Firmenich Receives FDA Approval On Bemotrizinol (Parsol Shield)
10/06/2026 12:31
BRIEF-dsm-Firmenich Receives FDA Approval On Bemotrizinol (Parsol Shield) June 10 (Reuters) - dsm-firmenich AG DSFIR.AS:
RECEIVES FDA APPROVAL ON PARSOL SHIELD, A NEW SUN PROTECTION INGREDIENT FOR U.S.
Source text: ID:nNDL6JQ02S
Further company coverage: DSFIR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on DSM-Firmenich AG
See all newsEurope Research Roundup: DSM-Firmenich, ING Groep, Straumann Holding
Brief: dsm-Firmenich Receives FDA Approval On Bemotrizinol (Parsol Shield)
Europe's STOXX 600 closes subdued as oil rally fades; Italian banks in focus (updated)
Goldman Sachs flags downturn risk for Europe chemicals sector
Europe Research Roundup: Bayer, Ceres Power Holdings, EasyJet